High-grade serous ovarian cancer (HGSOC) is the most aggressive form of ovarian cancer, with a low five-year survival rate. To address this urgent need for new treatment options, researchers have turned to syngeneic mouse models as a game-changer in HGSOC research. These syngeneic models, derived from the same strain of mouse, provide a unique advantage…